Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease

European Journal of Human Genetics

Volumn 7, Issue 6, 1999, Pages 659-663

  Tilley, Louise ^a   Morgan, Kevin ^a   Grainger, Joe ^a   Marsters, Peter ^a   Morgan, Linda ^a   Lowe, James ^a   Xuereb, John ^b   Wischik, Charles ^b   Harrington, Charles ^c   Kalsheker, Noor ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alzheimer's disease; BChE gene; Polymorphisms; PS 1 gene

Indexed keywords

APOLIPOPROTEIN E4; CHOLINESTERASE; PRESENILIN 1;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PRESENILIN-1; RISK FACTORS;

EID: 0032880283     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200351     Document Type: Article

References (20)

1. Strittmatter WJ, Saunders AM, Schmechel D et al: Apolipoprotein-E-high-avidity binding to beta-amyloid and increased frequency of type-4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 1977-1981.
2. Polvikoski T, Sulkava R, Haltia M et al: Apolipoprotein-E. dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995; 339: 1242-1247.
3. Wragg M, Hutton M, Talbot C et al: Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996; 347: 509-512.
4. Kehoe P, Williams J, Lovestone S, Wilcock G, Owen MJ: Presenilin-1 polymorphism and Alzheimer's disease (letter). Lancet 1996; 347: 1186.
5. Higuchi S, Muramatsu T, Matsushita S, Arai H, Sasaki H: Presenilin-1 polymorphism and Alzheimer's disease (letter). Lancet 1996; 347: 1186.
6. Ezquerra M, Blesa R, Tolosa E et al: The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease. Neurosci Lett 1997; 227: 201-204.
7. Isoe K, Urakami K, Ji Y, Adachi Y, Nakashima K: Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population. Acta Neurol Scand 1996; 94: 326-328.
8. Matsushita S, Arai H, Muramatsu T et al: Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia. Exp Neurol 1997; 146: 567-569.
9. Scott WK, Roses AD, Haines JL, Pericak-Vance MA: Presenilin-1 polymorphism and Alzheimer's disease (letter). Lancet 1996; 347: 1560.
10. Perez-Tur J, Warrantdevrieze F, Lambert JC, Chartier-Harlin MC: Presenilin-1 polymorphism and Alzheimer's disease (letter). Lancet 1996; 347: 1560.
11. Tysoe C, Whittaker J, Cairns NJ et al: Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset alzheimer's disease. Neurosci Lett 1997; 222: 68-69.
12. Tysoe C, Galinsky D, Robinson D et al: Analysis of alpha-1-antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am J Med Gen 1997; 74: 207-212.
13. Lehmann DJ, Johnston C, Smith AD: Synergy between the genes for butyrylcholinesterase K variant and apoliprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet 1997; 6: 1933-1936.
14. Brindle N, Song E, Rogaeva SE et al: Analysis of the butyrylcholinesterase gene and nearby Chromosome 3 markers in Alzheimer's disease. Hum Mol Genet 1998; 7: 933-935.
15. Singleton AB, Smith G, Gibson AM et al: No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet 1998; 7: 937-939.
16. Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
17. Morgan K, Morgan L, Carpenter K et al. Microsatellite polymorphism of the alpha-1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum Genet 1997; 99: 27-31.
18. Jensen FS, Nielsen LR, Schwartz M: Detection of the plasma cholinesterase-K variant by PCR using an amplification-created restriction site. Hum Hered 1996; 46: 26-31.
19. Bickeboller H, Campion D, Brice A et al. Apolipoprotein E and Alzheimer's disease: genotype-specific risks by age and sex. Am J Hum Genet 1997; 60: 439-446.
20. Roses AD, Devlin B, Coneally PM et al. Measuring the genetic contribution of APOE in late-onset Alzheimer's disease (AD) (abstract). Am J Hum Genet 1995; 57 (suppl): A202.